Piciclib 75mg (Palbociclib)

Palbociclib, also known as Piciclib 75mg, is a kinase inhibitor medication used to treat hormone receptor-positive and HER2-negative advanced or metastatic breast cancer in women. It is usually prescribed alongside an aromatase inhibitor or fulvestrant, depending on the patient's specific condition.

DOSAGE AND ADMINISTRATION

A recommended starting point would be to orally consume 125mg once per day with food for 21 consecutive days, followed by a 7-day break from treatment. Any necessary adjustments to the dosage should be made based on the individual's safety and tolerance.

How much does palbociclib cost:

Palbociclib costs only 8% of its price in the United States when purchased in India. The generic version of Palbociclib, which contains the same active ingredient and adheres to the same pharmaceutical standards as the brand-name version, requires a prescription.

Piciclib 75mg (Palbociclib) Side Effects：

Palbociclib can cause several common side effects, including reduced counts of white blood cells, red blood cells, and platelets, as well as fatigue, nausea, mouth sores, diarrhea, hair loss or thinning, vomiting, rash, loss of appetite, and abnormal liver blood test results. Monitoring blood cell counts regularly is essential as low white blood cell counts can increase the risk of severe infections. Healthcare providers may need to interrupt treatment, lower the dosage, or delay the start of a new cycle if necessary. Additionally, Palbociclib may affect male fertility.

For more Prescribing information，please check the → “FDA Prescribing Information